Latest Articles
- Failure to thrive in hospitalized older adults: More than a ‘social admission’
Failure to thrive documented as an admitting diagnosis presents an opportunity to identify, articulate, and begin to ameliorate the true underlying causes of the patient’s health deficits.
- What is the optimal time for bone density screening in patients with premature ovarian insufficiency?
Dual-energy x-ray absorptiometry should be performed at diagnosis, with the timing of repeat scans predicated on the patient’s clinical risk factors for fracture.
- Nearly a century of using glucocorticoids in patients with active infection
Why would we consider dampening the immune response with glucocorticoids when a patient has an active infection?
- MDA5 dermatomyositis: Unveiling a potentially life-threatening disease
Timely diagnosis and initiation of aggressive immunosuppressive therapy are key to improving the 40% overall mortality rate in patients with MDA5 dermatomyositis.
- Hold ACE inhibitors and ARBs before noncardiac surgery? Emerging evidence suggests a patient-specific approach
Judicious withholding of ACE inhibitors and ARBs in vulnerable populations—and promptly resuming them—may strike the safest balance between renal protection and hemodynamic stability.
- Do patients with severe community-acquired bacterial pneumonia benefit from systemic corticosteroids?
Recent evidence has swung the pendulum back in favor of using corticosteroids in patients with severe community-acquired pneumonia.
Low-dose colchicine for management of coronary artery diseaseCurrent guidelines endorse adding low-dose colchicine to standard medical therapy for coronary artery disease prevention, but data show clinicians remain hesitant to use it for this indication.
